Results 241 to 250 of about 3,196,686 (255)

STUDY FINDS UP TO HALF OF PHASE III CLINICAL TRIALS SUCCESSFUL

Ca-A Cancer Journal for Clinicians, 2008
exaly  

Phase I trials as therapeutic options: (usually) a betrayal of evidence-based medicine

Nature Reviews Clinical Oncology, 2019
Jonathan Kimmelman
exaly  

Reduced‐volume radiotherapy versus conventional‐volume radiotherapy after induction chemotherapy in nasopharyngeal carcinoma: An open‐label, noninferiority, multicenter, randomized phase 3 trial

Ca-A Cancer Journal for Clinicians
Ling-Long Tang, Wen-Fei Li, Xu Liu
exaly  

S-Phase Checkpoint

2011
openaire   +1 more source

S-phase Promoting Factor

2006
openaire   +1 more source

Fuzuloparib with or without apatinib as maintenance therapy in newly diagnosed, advanced ovarian cancer (FZOCUS‐1): A multicenter, randomized, double‐blind, placebo‐controlled phase 3 trial

Ca-A Cancer Journal for Clinicians
Jianqing Zhu, Mo Chen, Ning Li
exaly  

S-Phase Promoting Factor

2008
openaire   +1 more source

S-Phase Damage-Sensing Checkpoints

2008
Jun Mi, Joyce L. Hamlin, James M. Larner
openaire   +1 more source

A switch for S phase

Nature, 2007
openaire   +1 more source

Phase Engineering of Nanostructural Metallic Materials: Classification, Structures, and Applications

Chemical Reviews
Fenghui Duan, Wenhao Cha, Jian Lu
exaly